Go back

UK trade bodies warn against waiving Covid vaccine patents

   

Pharma and bioindustry associations criticise recent US support for waiving intellectual property for the jabs

UK bioscience industry and pharmaceutical leaders have warned against waiving intellectual property for Covid-19 vaccines.

Their intervention comes after the United States trade representative Katherine Tai said the US would “actively participate” in negotiations at the World Trade Organization to make the waiver happen, adding that “the extraordinary circumstances of the Covid-19 pandemic call for extraordinary measures”.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.